Regina Barragan-Carrillo (@ReginaBarCar) / X

Regina Barragan-Carrillo

970 posts

Regina Barragan-Carrillo

@ReginaBarCar

🇲🇽 GU Oncologist @incanMx 2025-/ Postdoc @CityofHope 2023-2025/ @JCOGO_ASCO Editorial Fellow 2022-2023

INCan

Joined April 2018

Pinned
Regina Barragan-Carrillo
@ReginaBarCar
Dec 18, 2023
I had a chance to talk at @ASCO Connection about myself, my unusual career path coming from 🇲🇽, and the impact that mentorship has had on my professional development. Special thanks to @ASCOTECAG for the opportunity to share my story! connection.asco.org/magazine/featu…
48K
Regina Barragan-Carrillo
@ReginaBarCar
Feb 28, 2023
Finally, Medical Oncologist
70K
Regina Barragan-Carrillo
@ReginaBarCar
Jan 23, 2024
Me, whenever I have to prepare a talk in English
22K
Regina Barragan-Carrillo
@ReginaBarCar
Apr 23, 2022
I am incredibly excited to share that I have been selected for the @ASCO Editorial Fellowship. Looking forward to working with the JCO Global Oncology @JCOGO_ASCO team to highlight the international perspective! #latinasinmedicine
Regina Barragan-Carrillo
@ReginaBarCar
Mar 10, 2025
Just one taste of what a 2 year fellowship with @montypal and the GU team with @TDorffOnc, @arafflemd and @AbhiTrip87 at @cityofhope looks like! I can't express how grateful I am for this incredible experience. After 14 years of medical training, I’m so excited to finally step
9.2K
Regina Barragan-Carrillo
@ReginaBarCar
Nov 7, 2024
🚨 New Paper Alert! 🚨 Excited to share our latest review on 1st and 2nd -line treatments in mRCC in @EUplatinum , co-authored by @ReneeSaliby, @eddy_saad, @maxinesun, and @DrChoueiri among many of the leading experts in the fields. Check it out! authors.elsevier.com/c/1k2yF14kplyz… (0/10)
28K
Regina Barragan-Carrillo
@ReginaBarCar
Sep 29, 2022
Ready to go! Very nervous about my first oral presentation @asco #ASCOQLTY22 but at least I get to share the stage with @crisbergerot Any last minute tips from the experts? @montypal @NazliDizman @NarjustFlorezMD @AnaVManana @LuisMezaco @ZeynepZengin @EnriqueSoto8 @BourlonMaite
Regina Barragan-Carrillo
@ReginaBarCar
Sep 14, 2024
No other person has impacted my career as an Oncologist as these two! @Dra_CVillarreal and @montypal have been amazing and generous mentors; luckily, they are my excellent friends. I am happy that they could finally meet each other during #ESMO2024
5.8K
Regina Barragan-Carrillo
@ReginaBarCar
Apr 30, 2022
Two great news in a single week! I will be part of the @ASCO Trainee and Early Career Advisory Group. I am honored to have the opportunity to voice the concerns from the LatinX trainee community! #latinasinmedicine @LatinxOncology
Regina Barragan-Carrillo
@ReginaBarCar
Jul 26, 2022
Super excited to share our data on transgender health 🏳️‍⚧️ and my first oral presentation at an @ASCO meeting #ASCOQLTY22. Back to Chicago! @yaninchavarri @HemOncINCMNSZ @LatinxOncology #latinasinmedicine
Regina Barragan-Carrillo
@ReginaBarCar
Feb 18, 2023
Ten days away from finishing my Oncology fellowship @incmnszmx, and we got to do the last Grand Rounds for the academic year and the last day of outpatient clinic
13K
Regina Barragan-Carrillo
@ReginaBarCar
Jan 31, 2024
I am happy to discuss our ongoing trial for the first-line treatment of metastatic renal cell carcinoma (#mRCC). We are using a unique approach that combines camu camu, a Brazilian berry, with nivolumab+ipilimumab If you are interested in learning more about the trial, we are
GU Oncology Now
@GUOncologyNow
Jan 30, 2024
Dr. Regina Barragán-Carrillo (@ReginaBarCar) provided an overview of her research on the difference between treatment with #nivolumab and #ipilimumab versus extract from the comestible camu camu berry in patients with #mRCC. Learn More: buff.ly/3HAKLca
00:00
22K
Regina Barragan-Carrillo
@ReginaBarCar
Jul 15, 2025
🔥 What’s the hottest topic in oncology right now? CANCER + THE MICROBIOME. We reviewed the current evidence on how manipulating the gut microbiome can enhance immunotherapy, and what’s next. Led by @montypal with insights from @ZeynepZengin and me. 📍Read here:
7.6K
Regina Barragan-Carrillo
@ReginaBarCar
Jun 9, 2025
Adjuvant Nivolumab in MIUC – Real-World Data with a Focus on Disparities led by @arafflemd A quick tweetorial 🧵 ⁉️ Can real-world outcomes of adjuvant nivolumab match those from clinical trials? And how does it perform in underrepresented groups? ➡️We evaluated 253 patients
10K